Elze Moreira Da Cunha Rabeloel
⚠️ Moderate Risk
FEI: 3004725793 • Recife, Bahia • BRAZIL
FEI Number
3004725793
Location
Recife, Bahia
Country
BRAZILAddress
Cpf 168512934 04, , Recife, Bahia, Brazil
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
Frequently Asked Questions
What is Elze Moreira Da Cunha Rabeloel's FDA import refusal history?
Elze Moreira Da Cunha Rabeloel (FEI: 3004725793) has 2 FDA import refusal record(s) in our database, spanning from 11/18/2004 to 11/18/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Elze Moreira Da Cunha Rabeloel's FEI number is 3004725793.
What types of violations has Elze Moreira Da Cunha Rabeloel received?
Elze Moreira Da Cunha Rabeloel has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Elze Moreira Da Cunha Rabeloel come from?
All FDA import refusal data for Elze Moreira Da Cunha Rabeloel is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.